Compare Becton Dickinson and Co (BDX) vs Abrdn Physical Platinum Shares ETF (PPLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Abrdn Physical Platinum Shares ETF — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $41.51B), while Abrdn Physical Platinum Shares ETF trades at $14.74. The key difference: Becton Dickinson and Co pays a 2.79% dividend while Abrdn Physical Platinum Shares ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| BDX | PPLT | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $185.39 | $25.23 |
52-Week Low | $135.49 | $11.78 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
PPLT trades at $14.52, down 1.69% with a bearish technical outlook showing 15 sell signals versus 0 buy signals. The ETF recently underwent a 1:10 stock split effective May 18, 2026, which adjusted share count without changing the fund's underlying value. Platinum has underperformed other precious metals recently, creating potential catch-up trade opportunities according to market commentary.
The outlook remains cautious as platinum lags gold's rally, though some analysts see long-term potential. Key risks include precious metals volatility and correlation dynamics. Recent downgrades to 'Hold' suggest limited near-term upside after PPLT's 84-100% returns over the past year, requiring careful entry timing for new positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Abrdn Physical Platinum Shares ETF
PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →
